Skip to main content
SpringerLink
Log in

Varied biologic functions of c-reactive protein

Lessons learned from transgenic mice

  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Our investigations of human C-reactive protein (CRP) and CRP transgenic mice have produced novel data that firmly establish this protein as an important host defense molecule. For example, we have learned that depending on the disease model, the beneficial effect of CRP can be direct, depend on the protein's ability to engage complement and Fcγreceptors, or rely on its ability to bridge innate and adaptive immunity. In addition, the degree of protection correlates with acute phase expression, but more important, also with the amount of CRP expressed constitutively. Furthermore, differences in baseline levels of CRP among healthy individuals and among patients can be attributed to a CRP gene polymorphism. In this article, we discuss these and other observations we have made during the last 5 yr and summarize our ongoing studies and future plans related to CRP biology.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Abernathy TJ, Avery OT: The occurrence duringacute infections of a protein not normally present in the blood. I. Distribution of the reactive protein in patient's sera and the effect of calcium on the flocculation reaction with C-polysaccharide of pneumococcus. J Exp Med 1941;73:173–182.

    Article  Google Scholar 

  2. Shrive AK, Cheetham GMT, Holden D, Myles DAA, Turnell WG, Volanakis JE, Pepys MB, Bloomer AC, Greenhough TJ: Three dimensional structure of human C-reactive protein. Nat Struct Biol 1996;3:346–354.

    Article  PubMed  CAS  Google Scholar 

  3. Anderson JK, Stroud RM, Volanakis JE: Studies on the binding specificity of human C-reactive protein for phosphorylcholine. Fed Proc 1978;37:1495.

    Google Scholar 

  4. Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE. C-reactive protein: structural biology, gene expression, and host-defense function. Immunol Res 1997;16:127–136.

    Article  PubMed  CAS  Google Scholar 

  5. Szalai AJ, Agrawal A, Greenhough TJ, Volanakis JE: C-reactive protein: structural biology and host-defense function. Clin Chem Lab Med 1999;37:265–270.

    Article  PubMed  CAS  Google Scholar 

  6. Szalai AJ: Thean timicrobial activity of C-reactive protein. Microb Infect 2001;4:201–205.

    Article  Google Scholar 

  7. Agrawal A, Volanakis JE: Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis. J Immunol 1994;152: 5404–5410.

    PubMed  CAS  Google Scholar 

  8. Marnell LL, Mold C, Volzer MA, Burlingame RW, DuClos TW: C-reactive protein binds to Fc7R1 in transfected COS cells. J Immunol 1995;155:2185–2193.

    PubMed  CAS  Google Scholar 

  9. Bharadwaj D, Stein M-P, Volzer M, Mold C, DuClos TW: The major receptor for C-reactive protein on leukocytes is Fc7 receptor II. J Exp Med 1999;190:585–590.

    Article  PubMed  CAS  Google Scholar 

  10. Mold C, Gewurz H, Du Clos TW: Regulation of complement activation by C-reactive protein. Immuno pharmacology 1999;422:23–30.

    Article  Google Scholar 

  11. Pepys MB, Baltz ML, Gomer K, Davies AJS, Doenhoff M: Serum amyloid P component is an acutephase reactantin the mouse. Nature 1979;278:259–261.

    Article  PubMed  CAS  Google Scholar 

  12. Ciliberto G, Arcone R, Wagner EF, Rüther U: Inducible and tissuespecific expression of human C-reactive protein in transgenic mice. EMBO J 1987;6:4017–4022.

    PubMed  CAS  Google Scholar 

  13. Murphy C, Beckers J, Rüther U: Regulation of the humanC-reactive protein gene in transgenic mice. J Biol Chem 1995;270: 704–708.

    Article  PubMed  CAS  Google Scholar 

  14. Szalai AJ, Briles DE, Volanakis JE: Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J Immunol 1995;155: 2557–2563.

    PubMed  CAS  Google Scholar 

  15. Yamada S, Gotoh T, Nakashima Y, Kayaba K, Ishikawa S, Nago N, Nakamura Y, Itoh Y, Kajii E: Distribution of serum C-reactive protein and its association with atherosclerosis risk factors in a Japanese population. Am J Epidemiol 2001;153:1183–1190.

    Article  PubMed  CAS  Google Scholar 

  16. Szalai AJ, van Ginkel FW, Wang Y, McGhee JR, Volanakis JE: Complement-dependent acute-phase expression of C-reactive protein and serum amy loid P-component. J Immunol 2000;165:1030–1035.

    PubMed  CAS  Google Scholar 

  17. Szalai AJ, Van Cott JL, McGhee JR, Volanakis JE, Benjamin WH Jr: Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice. Infect Immun 2000;68:5652–5656.

    Article  PubMed  CAS  Google Scholar 

  18. Burlingame RW, Volzer MA, Harris J, Du Clos TW: The effects of acute phase proteins on clearance of chromatin from the circulation of normal mice. J Immunol 1996;156:4783–4788.

    PubMed  CAS  Google Scholar 

  19. Du Clos TW, Zlock LT, Hicks PS, Mold C: Decreased autoantibody levels and enhanced survival of (NZB XNZW)F, mice treated with C-reactive protein. Clin Immunol Immunopathol 1994;70: 22–27.

    Article  PubMed  Google Scholar 

  20. Gershoy D, Kim S, Brot N, Elkon KB: C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemicautoimmunity. J Exp Med 2000;192:1353–1363.

    Article  Google Scholar 

  21. Szalai AJ, Marion TN, Weaver CT, Volanakis JE: Human C-reactive protein(CRP) is protective against murine SLE in NZB/W F1 mice. Clin Exp Rheum 1998;16: 201.

    Google Scholar 

  22. Szalai AJ, Nataf S, Hu X-Z, Bamum SR: Experimentalallergic encephalomyelitis is inhibited in transgenic mice expressing human c-reactive protein. J Immunol 2002;168:in press.

  23. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease inapparently healthy men. N Engl J Med 1997;336:973–979.

    Article  PubMed  CAS  Google Scholar 

  24. Westhuyzen J, Healy H: Review: biology and relevance of C-reactive protein in cardiovascular and renal disease. Ann Clin Lab Sci 2000; 30:133–143.

    PubMed  CAS  Google Scholar 

  25. Lei K-J, Liu T, Zon G, Soravia E, Liu T-Y, Goldman ND: Genomic DNA sequence for human C-reactive protein. J Biol Chem 1985; 260:13,377–13,383.

    CAS  Google Scholar 

  26. Woo P, Korenberg JR, Whitehead AS: Characterization of genomic and complem entary DNA sequence of human C-reactive protein, and comparison with the complementary sequence of serum amyloid P component. J Biol Chem 1985; 260:13,384–13,388.

    CAS  Google Scholar 

  27. Weber JL, Kwitek AE, May PE: Dinucleotide repeatpolymorphism at the CRP locus. Nucl Acid Res 1990;18:4635.

    Google Scholar 

  28. Szalai AJ, McCrory A, Cooper GS, Wu J, Kimberly RP: Association between baseline levels of C-reactive protein (CRP) andadin-ucleotide repeat polymorphism in the intron of the CRP gene. Gene Immun 2002;3:14–19.

    Article  CAS  Google Scholar 

  29. Adler AJ, Scheller A, Robins DM: The stringency and magnitude of androgen-specific gene activation are combina torial functions of receptor and nonreceptor binding site sequences. Mol Cell Biol 1993; 13:6326–6335.

    PubMed  CAS  Google Scholar 

  30. Lutgens E, Daemen M, Kockx M, Doevendans P, Hofker M, Havekes L, Wellens H, de Muinck ED: Atherosc lerosis in APOE*3-Leiden transgenicmice: from proliferative to a the romato usstage. Circulation 1999;99:276–283.

    PubMed  CAS  Google Scholar 

  31. Van Molle W, Denecker G, Rodriguez I, Brouckaert P, Vandenabeele P, Libert C: Activation of caspases in lethal experimental hepatitis and prevention by acute phase proteins. J Immunol 1999; 163:5235–5241.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Deparment of Medicine, Division of Clinical Immunology and Rheumatology THT 437B, University of Alabama at Birmingham, 35294-0006, Birmingham, AL

    Alexander J. Szalai & Mark A. McCrory

Authors
  1. Alexander J. Szalai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark A. McCrory
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander J. Szalai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Szalai, A.J., McCrory, M.A. Varied biologic functions of c-reactive protein. Immunol Res 26, 279–287 (2002). https://doi.org/10.1385/IR:26:1-3:279

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1385/IR:26:1-3:279

Key Words

Search

Navigation